Pfizer Inc. (PFE)
25.68
+0.06
(+0.23%)
USD |
NYSE |
Jun 09, 16:00
25.70
+0.02
(+0.08%)
After-Hours: 18:46
Pfizer Research and Development Expense (Quarterly) : 2.452B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.495B |
| Eli Lilly & Co. | 3.51B |
| Merck & Co., Inc. | 11.98B |
| Viatris, Inc. | 245.20M |
| Bristol Myers Squibb Co. | 2.238B |